RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
Psoriasis vulgaris
View Complete Description-
Pathogenesis and clinical features of psoriasis.
Lancet 2007 Jul 21 -
Evidence for susceptibility determinant(s) to psoriasis vulgaris in or near PTPN22 in German patients.
Authors: U Hüffmeier, M Steffens, H Burkhardt, J Lascorz, F Schürmeier-Horst, M Ständer, R Kelsch, C Baumann, W Küster, R Mössner,…
Journal of medical genetics 2006 Jun
Thought leaders and organizations working on research involving psoriasis vulgaris.
- LEO Pharma
- Rockefeller University
- Bristol-Myers Squibb
- Dresden University of Technology
- Innovaderm Research Inc.
- University of Erlangen-Nuremberg
- Wroclaw Medical University
- Charité-Universitätsmedizin Berlin
- Rockefeller University
- University of Manchester
-
Determination of Lymphocyte JAM-C Expression in Patients With Psoriasis Vulgaris
conditions: Psoriasis ; Psoriasis Vulgaris
interventions: none
-
Taclonex Ointment With Hydrogel Patch Occlusion for the Treatment of Psoriasis
conditions: Plaque Psoriasis ; Psoriasis Vulgaris
interventions: Taclonex Ointment and Hydrogel Patch ; Taclonex Ointment
Community
Head, Biostatistics, Epidemiology, and Research Design
The Rockefeller University Center for Clinical and Translational Science
-
No NextBio groups were found for “psoriasis vulgaris”.
Be the first to start a group and share your interests with others within the NextBio community.
